A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)

Clinical trial NCT05564039 · COMPLETED

Trial details

NCT number: NCT05564039
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2022-11-30
Primary completion: 2024-07-15
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.